기업명 | 주식 심볼 | 시장 | 주식 타입 |
---|---|---|---|
InVivo Therapeutics Holdings Corporation | NVIV | 나스닥 | 보통주 |
개장가 | 저가 | 고가 | 종가 | 전일 종가 |
---|---|---|---|---|
0.3207 |
최근 뉴스
일자 | 시간 | 출처 | 제목 |
---|---|---|---|
22/03/2024 | 03:23 | EDGAR2 | Form 25-NSE - Notification filed by national security.. |
15/02/2024 | 04:53 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
14/02/2024 | 10:09 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
08/02/2024 | 04:12 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
08/02/2024 | 03:31 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
07/02/2024 | 02:08 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
06/02/2024 | 22:00 | EDGAR2 | Form 8-K - Current report |
01/02/2024 | 22:00 | EDGAR2 | Form 8-K - Current report |
05/12/2023 | 22:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
02/12/2023 | 06:30 | EDGAR2 | Form 8-K - Current report |
01/12/2023 | 00:31 | EDGAR2 | Form 8-K - Current report |
09/11/2023 | 06:31 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
02/09/2023 | 05:30 | EDGAR2 | Form 8-K - Current report |
10/08/2023 | 05:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |